IV Iron Replacements Go Head-to-Head for IBD-Related Anemia Trial confirms higher rate of hypophosphatemia with ferric carboxymaltose Sep 16, 2022
PK Modulator Shows Promise in Thalassemia In small study, mitapivat increased hemoglobin in 80% of non-transfusion-dependent patients Aug 17, 2022
Kidney Failure May Drive COVID Deaths in People With Sickle Cell Trait COVID-19 severity strongly linked with sickle cell anemia as well Jun 27, 2022
Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults Study finds risk was low, but unequal across different products Mar 28, 2022
Finally, a 'New Standard' for Severe Aplastic Anemia After 3 decades of failures, RACE trial shows superiority of new first-line regimen Jan 05, 2022
Investigational Oral CKD-Anemia Agent Effective, Safe HIF-PHI daprodustat increased hemoglobin without hurting heart Nov 05, 2021
Are Hemoglobin Cutoffs for Anemia Outdated? A growing call for WHO criteria to be tightened Aug 06, 2021
Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drug Advisory committee rejected oral anemia drug for dialysis and non-dialysis patient populations Jul 16, 2021
'Acceptable' Lead in Drinking Water May Still Be Harmful to Patients With CKD No safe amount of lead in water for those with kidney disease, researchers warn Jul 15, 2021
Vadadustat Matches Standard for CKD-Related Anemia, With Caveat Jury still out on drug's heart safety, which differed depending on dialysis dependence Apr 28, 2021
More Top Research From Kidney Week 2020 Additional studies on anemia, heart risk, and racial disparities in chronic kidney disease Oct 27, 2020
Newborns Getting Preoperative Blood Transfusions Have More Complications Data favor restrictive transfusion strategy Oct 22, 2020
New Anemia Linked to Crohn’s Disease but Not Ulcerative Colitis Risk Anemia seen as promising surrogate marker for preclinical CD, especially in men Sep 11, 2020
REALITY Check: Stricter RBC Transfusion Safe for Anemic MI Patients Restrictive strategy makes sense for clinical outcomes, costs Sep 01, 2020
Red Cell Distribution Width Strongly Predicts Hip Fracture Simple way to identify at-risk patients Sep 24, 2019
Could Mom's Anemia Hurt Baby's Brain? Association study suggests an increased risk, though still quite small Sep 18, 2019
$2 Test Could Transform Sickle Cell Dx in Africa May have applications in high-income countries as well Dec 04, 2018
ASH Offers Early Look at Updated SCD Guidelines Experts formulated >50 recommendations on sickle cell disease Dec 03, 2018
Sneak Peek at Practice-Changing Research From ASH 2018 "Big trials, big results," plus sickle cell disease and CAR T-cell therapies Nov 30, 2018
SGLT-2 for Stage 3 CKD; Opioids for CKD; Kidney Transplant Discard & Disabilities Roundup of more top abstracts from Kidney Week 2018 Oct 30, 2018
High-Dose Iron an Option for Maintenance Hemodialysis High-dose noninferior to low-dose, required less erythropoiesis-stimulating agent Oct 28, 2018
Sickle Cell in the ED: Old Therapies, New Strategies With treatments unchanged in decades, docs seek to improve delivery Oct 02, 2018
Decades Later, Mortality for Childhood Transplant Recipients Remains High Elevated risk requires closer follow-up care Jul 27, 2018
Post-Op Gastric Bypass Care Vital for Preventing Anemia 10 years after surgery, most who didn't seek post-op care developed anemia Sep 22, 2017
MSK Cancer Alliance: Mainly About Medicine Bi-directional relationship strengthens regional cancer care Mar 11, 2017
Part 2: Oncologists Weigh In on PBS Cancer Documentary Six specialists share their impressions of Ken Burns' cancer opus. Apr 13, 2015
Fatal Reactions Prompt Omontys Recall All lots of the new anemia drug peginesatide (Omontys) have been recalled because of severe hypersensitivity reactions -- some fatal -- observed after the drug was approved last March. Feb 24, 2013
Judge OKs $762 Million Deal in Aranesp Case A federal judge approved a $762 million settlement Wednesday in a case involving Amgen's off-label promotion of darbepoetin alfa (Aranesp), an anemia drug. Dec 20, 2012
Amgen Agrees to Pay $762 Million in Aranesp Case The biotech drug giant Amgen pled guilty Monday to promoting its blockbuster anemia drug darbepoetin alfa (Aranesp) for off-label dosing regimens, agreeing to pay $762 million in fines. Dec 18, 2012
Anemia a Risk with Low-Dose IVIG, Too Even small doses of intravenous immune globulin (IVIG) can cause acute, severe anemia, researchers warned. Sep 06, 2012
Doctors Say 45 Common Tests 'Overused' Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project. Apr 04, 2012
Anemia Worsens Surgical Outcomes Patients who are anemic before going into surgery are at greater risk of death and other complications, researchers found. Oct 06, 2011
